JavaScript is disabled in your browser. Please enable JavaScript to view this website.

SLC6A5

Function

Sodium- and chloride-dependent glycine transporter (PubMed:10381548, PubMed:10606742, PubMed:16751771, PubMed:31370103, PubMed:9845349). Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals (PubMed:9845349). May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses (PubMed:9845349).

Isoform 2

Lacks sodium- and chloride-dependent glycine transporter activity.

Isoform 3

Lacks sodium- and chloride-dependent glycine transporter activity.

Involvement in disease

Hyperekplexia 3

HKPX3

A neurologic disorder characterized by neonatal hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. Notably, in some cases, symptoms resolved in the first year of life.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

N-glycosylated.

Sequence Similarities

Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. SLC6A5 subfamily.

Tissue Specificity

Expressed in medulla, and to a lesser extent in spinal cord and cerebellum.

Cellular localization

Alternative names

GLYT2, NET1, SLC6A5, Sodium- and chloride-dependent glycine transporter 2, GlyT-2, GlyT2, Solute carrier family 6 member 5

swissprot:Q9Y345 omim:604159 entrezGene:9152